BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

4 hedge funds and large institutions have $0 invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.

Holders
4
Holders Change
-4
Holders Change %
-50%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change